For the quarter ending 2026-03-31, USBC had -$2,057,261 decrease in cash & cash equivalents over the period.
| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|
| Net loss | -25,554,769 | -27,455,848 | -22,123,349 |
| Depreciation and amortization | 6,184 | 6,882 | 31,367 |
| Loss on disposal of fixed assets | -22,363 | - | - |
| Stock based compensation - stock option grants | 3,925,225 | 11,868,452 | 7,407,088 |
| Issuance of common stock for services | - | 0 | 1,096,142 |
| Provision for credit losses | 2,176,824 | - | - |
| Amortization of operating lease right-of-use asset | 32,012 | 31,575 | 119,228 |
| Loss on debt extinguishment | - | 0 | 942,462 |
| Interest expense for default of convertible notes | - | 0 | 748,600 |
| Interest expense for repricing of warrants | - | 0 | 233,916 |
| Interest expense for extension of notes and warrants | - | 0 | 513,499 |
| Interest expense for default of convertible notes | 0 | - | - |
| Amortization of debt issuance costs | 0 | 11,070 | 1,185,691 |
| Change in fair value of digital assets | -20,004,465 | -27,192,987 | -823,062 |
| Other derivative income, net | 1,556,719 | 1,101,011 | 283,154 |
| Deferred income taxes | -6,739,925 | -15,736,607 | -172,843 |
| Prepaid expenses | 195,276 | 63,144 | 228,030 |
| Operating lease right-of-use liability | -19,984 | -19,545 | -103,925 |
| Derivative liabilities | -485,667 | -215,233 | - |
| Digital assets | - | 1,136,515 | - |
| Digital assets - receivable, net | 2,404,388 | - | - |
| Derivative assets | -1,609,902 | -1,747,833 | - |
| Other long-term assets | - | 0 | 125,000 |
| Accounts payable - trade, related parties and accrued expenses | - | - | -2,089,538 |
| Accounts payable - trade and accrued expenses | 2,122,162 | 238,910 | - |
| Net cash used in operating activities | -7,057,591 | -4,630,194 | -7,595,708 |
| Purchase of research and development equipment | - | 0 | 0 |
| Net cash used in investing activities | 0 | 0 | 0 |
| Proceeds from issuance of common stock - goldeneye 1995 llc investment | - | 0 | 15,000,000 |
| Proceeds from issuance of common stock offering, net | - | 0 | 300,000 |
| Proceeds from loan payable | 5,000,000 | - | - |
| Proceeds from issuance of common stock for warrant exercise | - | 0 | 0 |
| Proceeds from debt offering | 0 | - | - |
| Proceeds from issuance of common stock for stock option exercise | 330 | 0 | 1,284,351 |
| Redemption of series h preferred stock | - | 0 | 514,067 |
| Repayment of convertible notes payable | - | 99,497 | 3,419,332 |
| Proceeds from convertible notes payable | - | 0 | 656,000 |
| Proceeds from at the market common stock offering | 0 | - | - |
| Net cash provided by financing activities | 5,000,330 | -99,497 | 13,306,952 |
| Net decrease in cash and cash equivalents | -2,057,261 | -4,729,691 | 5,711,244 |
| Cash and cash equivalents, beginning of period | 4,092,308 | 8,821,999 | 3,110,755 |
| Cash and cash equivalents, end of period | 2,035,047 | 4,092,308 | 8,821,999 |
USBC, Inc. (USBC)
USBC, Inc. (USBC)